How has been the historical performance of Hind.Organ.Chem.?

Answer:The historical performance of Hind.Organ.Chem. shows significant fluctuations in key financial metrics over the years.

Breakdown:
Hind.Organ.Chem. reported net sales of 535.87 Cr in March 2025, a decline from 703.89 Cr in March 2024 and 631.44 Cr in March 2023, but an increase from 433.68 Cr in March 2022. The total operating income mirrored this trend, with a total of 535.87 Cr in March 2025, down from 703.89 Cr in the previous year. The company faced rising raw material costs, which reached 426.95 Cr in March 2025, compared to 503.05 Cr in March 2024. Operating profit (PBDIT) turned negative at -63.38 Cr in March 2025, contrasting with a positive 15.70 Cr in March 2024. Profit before tax showed a recovery to 394.87 Cr in March 2025, after a loss of -55.32 Cr in March 2024. The profit after tax also improved significantly to 391.54 Cr in March 2025, compared to a loss of -55.32 Cr in the previous year. The company's total liabilities decreased to 1,564.37 Cr in March 2025 from 1,572.34 Cr in March 2024, while total assets slightly declined to 1,564.37 Cr in March 2025. The cash flow from operating activities turned positive at 631.00 Cr in March 2025, a significant improvement from -65.00 Cr in March 2024. Overall, the financial performance of Hind.Organ.Chem. reflects a challenging environment with notable recovery in profitability metrics in the latest fiscal year.